Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1988 Feb;41(2):202–206. doi: 10.1136/jcp.41.2.202

Quantitative method for determining serum alkaline phosphatase isoenzyme activity: estimation of intestinal component.

M J Peake 1, M Pejakovic 1, G H White 1
PMCID: PMC1141379  PMID: 3350981

Abstract

Intestinal alkaline phosphatase activity was measured using levamisole inhibition, and results were compared with a previously reported method using L-phenylalanine. Sixty two per cent intestinal, 39% placental, and 1.3% of either bone or liver alkaline phosphatase activity remained when alkaline phosphatase activity was inhibited in a 2-amino-2-methyl-1-propanol (AMP) buffer reagent system with 10 mmol/l levamisole (final assay concentration 8.1 mmol/l). The assay imprecision (SD) was 0.6 U/l compared with 3.9 U/l using L-phenylalanine for specimens with total alkaline phosphatase activity less than 250 U/l (reference range 30-120 U/l). In serum pools with raised total alkaline phosphatase activity errors in recovered intestinal activity were small (usually less than 3 U/l) when intestinal alkaline phosphatase was added. Much larger errors and many underestimated results were found using L-phenylalanine. For non-haemolysed specimens it is concluded that an assay based on levamisole inhibition provides a better measure of intestinal alkaline phosphatase activity than L-phenylalanine.

Full text

PDF
202

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brock D. J., Bedgood D., Barron L., Hayward C. Prospective prenatal diagnosis of cystic fibrosis. Lancet. 1985 May 25;1(8439):1175–1178. doi: 10.1016/s0140-6736(85)92860-0. [DOI] [PubMed] [Google Scholar]
  2. Dent C. E., Norris T. S., Smith R., Sutton R. A., Temperley J. M. Steatorrhoea with striking increase of plasma-alkaline-phosphatase of intestinal origin. Lancet. 1968 Jun 22;1(7556):1333–1336. doi: 10.1016/s0140-6736(68)92035-7. [DOI] [PubMed] [Google Scholar]
  3. Moss D. W. Alkaline phosphatase isoenzymes. Clin Chem. 1982 Oct;28(10):2007–2016. [PubMed] [Google Scholar]
  4. Shephard M. D., Peake M. J. Quantitative method for determining serum alkaline phosphatase isoenzyme activity I. Guanidine hydrochloride: new reagent for selectively inhibiting major serum isoenzymes of alkaline phosphatase. J Clin Pathol. 1986 Sep;39(9):1025–1030. doi: 10.1136/jcp.39.9.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Shephard M. D., Peake M. J., Walmsley R. N. Quantitative method for determining serum alkaline phosphatase isoenzyme activity II. Development and clinical application of method for measuring four serum alkaline phosphatase isoenzymes. J Clin Pathol. 1986 Sep;39(9):1031–1038. doi: 10.1136/jcp.39.9.1031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Stolbach L. L., Krant M. J., Inglis N. I., Fishman W. H. Correlation of serum L-phenylalanine-sensitive alkaline phosphatase, derived from intestine, with the ABO blood group of cirrhotics. Gastroenterology. 1967 May;52(5):819–827. [PubMed] [Google Scholar]
  7. Van Belle H. Alkaline phosphatase. I. Kinetics and inhibition by levamisole of purified isoenzymes from humans. Clin Chem. 1976 Jul;22(7):972–976. [PubMed] [Google Scholar]
  8. Walker A. W. Intestinal alkaline phosphatase in serum of patients on maintenance haemodialysis. Clin Chim Acta. 1974 Sep 30;55(3):399–405. doi: 10.1016/0009-8981(74)90015-1. [DOI] [PubMed] [Google Scholar]
  9. Warnes T. W., Hine P., Kay G. Intestinal alkaline phosphatase in the diagnosis of liver disease. Gut. 1977 Apr;18(4):274–278. doi: 10.1136/gut.18.4.274. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES